IGAS

This page shows the latest IGAS news and features for those working in and with pharma, biotech and healthcare.

J&J's Tremfya filed for approval in US for psoriatic arthritis

CRP), improvement in physical function (HAQ-DI), skin clearance (IGA) and quality of life (SF-36 PCS and MCS).

Tremfya heads for filing in psoriatic arthritis

DAS-28 CRP), improvement in physical function (HAQ-DI), skin clearance (IGA), and quality of life (SF-36 PCS and MCS).
Swedish biotech Calliditas signs China licensing deal for autoimmune candidate

Nefecon is a novel oral formulation of the corticosteroid budesonide which targets the active ingredient to B cells in the lower small intestine and control the output of IgA antibodies. ... Calliditas has one competitor in the field, Omeros, which is
Daily Brief: Karuna raises $42m for novel CNS approach, Chen exits Roche, Orchard gains GSK board member

Immunoglobulins, also known as antibodies, comprise a family of proteins that occur in five major forms: IgM, IgD, IgG, IgE and IgA.
Morning brief: Sanofi's shaky start, pharma begins talks with UK government and more

This is the second breakthrough therapy drug designation for OMS721, which gained the status last year for treatment of Immunoglobulin A (IgA) nephropathy, in which pivotal phase III trials recently begun.
Rigel and Ultragenyx claim approvals for rare drugs

Rigel is also developing it for additional indications, including autoimmune haemolytic anaemia and IgA nephropathy.

More from news
Approximately 1 fully matching, plus 11 partially matching documents found.

New hires at Nanoform, Leo Pharma and Calliditas

IgA nephropathy (IgAN) – also known as Berger’s disease. ... Currently, there are no approved treatments for IgA Nephropathy, and Nefecon has the potential to be a disease-modifying treatment for patients suffering from this chronic autoimmune disease

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Hayward Medical Communications launch a new, eye-opening journal

Hayward is particularly pleased that the journal features regular columns from the International Glaucoma Association (IGA) and the Royal National Institute of Blind People (RNIB). .

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Experienced / Senior Medical Writer - Excellent Progression Oppo...: Excellent Salary and Benefits on offer

Senior Account Manager / Account Director - MedComms - London: Highly competitive salary &package

Editorial Assistants - Medical Communications agency - Cheshire: Excellent Remuneration Package

Senior / Principal Medical Writers wanted - MedComms - Various U...: Excellent Remuneration Packages

Senior Medical Writer – Medical Communications – North West – In...: Excellent Remuneration Package

Add my company

JPA Health is an award-winning public relations, marketing and advocacy firm known for sharing our clients’ commitment to making people...

eyeforpharma Marketing and Customer Innovation Europe: By Richard Springham...
The Golden Goose: Why it’s so hard for the US to curb runaway drug prices...
What is changing in cardiovascular disease care?: Paul Midgley, of Wilmington Healthcare, explores the NHS Long-term Plan’s strategy for tackling cardiovascular disease and what it means for pharma...